Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Medical technology & services

Goodbody Health highlights significant phlebotomy progress

Goodbody Health Ltd (AQSE:GDBY, OTCQB:GDBYF) on Tuesday reported significant progress as it seeks to extend its phlebotomy services, signing agreements with blood testing partners.

Through a series of agreements – respectively with Rainbow Laboratories, Ted’s Health, Omnos, and Vitall – the company says it has access to a network of 90 clinics.

Customers can access this network through the Goodbody portal which in turn reduces dependency on Goodbody Clinic's direct-to-consumer online model.

"We are very excited about all the opportunities available to us and our expanding network of phlebotomists to support customers with their health and wellbeing through offering more options for blood testing,” said Goodbody chief executive George Thomas.

“As we have found from speaking to many providers and institutions in the space both in the finger-prick and venous draw markets, access to local clinics to take good quality blood draws has held back their access and growth, providing this service via our network gives us immediate growth and revenue opportunities.

“Marrying technology and healthcare services is a key part of strategy in 2023, and this is just the start."

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK